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ABSTRACT
Protein phosphatases play significant roles in signal transduction pathways
that regulate cellular processes in response to external/internal stimuli. They are
crucial for the growth, division, and differentiation of all organisms. Examples of cell
functions involving reversible phosphorylation include ion transport, metabolism, cell
cycle progression, developmental control, and stress responses. Serine/threoninespecific protein phosphatases are of particular interest in this study. There are two
types of serine/threonine-specific protein phosphatases: type 1 & type 2. Both
protein phosphatase 1 (PPl) and protein phosphatase 2A (PP2A) are inhibited by a
structurally diverse group of natural toxins produced by marine organisms that cause
diarrhetic shellfish poisoning. Recent research into diarrhetic shellfish poisoning has
contributed to the understanding of some of the mechanism of actions of cathartics.
It was learned that hydroxy acid moieties are essential for receptor binding of

diarrhetic shellfish toxins, such as okadaic acid, to the protein phosphatase enzymes
in the intestines which regulate ion channels. The loss of ion channel regulation in
the intestines leads to an efflux of electrolytes and water, causing diarrhea.
This study was undertaken in order to learn if four different crude cathartic
plant drugs whose active components contain hydroxy-acid moieties, will act
similarly to these diarrhetic shellfish toxins by inhibiting PP2A. First, two resin
glycosides, jalapin and convolvulin, were isolated from Ipomoea purga and Pharbitis

nil, of the Convolvulaceae family, respectively. After verifying their molecular
structures by proton nuclear magnetic resonance ( 1H NMR) spectroscopy, they were
tested against PP2A. Pure ricinoleic acid from Ricinis communis and
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podophyllotoxin from Podophyllum peltatum were purchased and also tested against
PP2A. A fluorometric assay, recently developed in Dr. Shimizu's lab, was used to
determine their activities toward protein phosphatase enzyme PP2A. The assay
results indicated weak but significant inhibition of PP2A by these compounds. The
doses of these crude drugs used to produce catharsis are six orders larger than the
dose of okadaic acid which causes diarrhea in humans. Thus the weak activities of
these compounds may be sufficient to account for the cathartic action of these drugs.
The bioavailability of these compounds in the human body is unknown. Since the
traditional standard dosages of these cathartics are too large to prepare as samples for
a micro-titer assay due to their solubilities, they were not able to be assayed at higher
concentrations at which more or total inhibition might take place. The possibility that
these crude cathartic drugs inhibit PP2A can not be discounted based on the results of
this study. It is also possible that these compounds may affect other enzymatic
activities which were not tested. This matter remains open to question.
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PREFACE
This thesis was prepared with the standard thesis plan of the University of
Rhode Island. The introduction will present an overview of the literature involved
with the background of Convolvulaceae plants, phosphatase research, and diarrheic
shellfish poisoning (DSP) including the 4-MUP assay for DSP detection.

An

Experimental chapter will be followed by a Results and Discussion chapter. Finally,
a Conclusion and Bibliography will be presented.
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INTRODUCTION
Cathartic and laxative plant drugs comprise a large class of important
crude drugs. In the past, cathartics were used extensively and were thought to
purge the body of a vast array of maladies. Among this class of crude plant drugs,
some of the more famous and officially recognized cathartics included croton oil,
castor oil, jalap roots, senna leaves, Cascara Sagrada bark, frangula bark, Aloe
spp., and rhubarb roots (United States Pharmacopeia XX, 1979). Despite their
widespread popularity and usage, only recently have a few mechanisms of action
of such cathartic drugs been elucidated. Many of these mechanisms still remain
unknown.
Senna leaves (Cassia angustifolia), Cascara Sagrada bark (Rhamnus

purshiana), Frangula bark (Rhamnus frangula) , the dried latex of Aloe leaves
(Alo e spp.) and rhubarb roots (Rh eum palmatum) all contain 1,8-oxygenated
derivatives of anthracene in the form of anthraquinone, anthrone and anthranol
(see Figure 1). They may occur as 0- and C glycosides. Glycosides of
anthranols and anthrones elicit a more drastic effect than do the anthraquinone
glycosides causing a discomforting, griping action. (Stahl, E., 1973). These
glycosides contribute significantly to the therapeutic activity of these crude plant
drugs (Tyler, V. et al. , 1988). Taken orally, the free anthraquinone aglycones
have little therapeutic activity, but in the glycosidic form the sugar moiety
facilitates absorption and trans location of the aglycone to the site of action in the
wall of the large intestine. Bacterial flora in the colon wall cleave the sugar
residues and free the aglycones at the site of action. The anthraquinone

glycosides and their derivatives are stimulant cathartics and exert their action by
increasing the tone of the smooth muscle in the wall of the colon. The exact
mechanisms of these actions are not yet known (Fairbairn, J.W., 1977).
Relatively recent studies involving croton oil, cholera toxin, and
diarrhetic shellfish poisoning have shed some light on the mechanisms by which
cathartics can act. These mechanisms of action involve interference with signal
transduction pathways responsible for regulating electrolyte balance.
Signal transduction regulates cellular processes in response to
external/internal stimuli and is crucial for the growth, division, and
differentiation of all organisms. Reversible protein phosphorylation is an
essential component of almost all signaling pathways in living cells. Changes in
the phosphorylation state of a protein are conducted by two types of enzyme
activities: protein kinases and protein phosphatases. Protein kinases catalyze the
covalent attachment of a phosphate group to an amino acid side chain, whereas
protein phosphatases reverse this process (Luan, 2000). The attachment to or
removal of a phosphate group from a protein often has profound effects on its
structure and thereby modifies the functional property of the protein.
Phosphorylation of key proteins with associated changes in their biological
activity accounts for many physiological responses. The phosphate content of
these proteins reflects a net balance of the protein kinases and protein
phosphatases acting on them (Hanks et al., 1988).
Phosphorylation of hydroxyl-bearing amino acid side chains (serine,
threonine, and tyrosine) is catalyzed by protein kinases (PKs) using ATP as a
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phosphoryl donor, whereas dephosphorylation is catalyzed by protein
phosphatases, which induce changes in protein conformation, protein-protein or
protein-ligand interactions, membrane permeability and solute gradients
(Sheppeck, et al., 1997). This simple cycle acts as an 'on-off switch to
selectively modulate the action of countless other proteins. Examples of enzyme
regulation by phosphorylation include initiation of allosteric conformational
changes which may directly block the access to an active site or regulation of the
interaction among protein partners that must form complexes in order to function.
Examples of cell functions involving reversible phosphorylation include ion
transport, metabolism, cell cycle progression, developmental control, and stress
responses.
Research conducted on croton oil points to the mechanisms by which
cathartics interfere with signal transduction. Croton oil is a naturally occurring
plant oil obtained from Croton tiglium, a shrub-like tree of the Euphorbiaceae
family (Evans, F .J ., 1986). Croton oil has been used traditionally in Western
medicine as a powerful purgative (Trease, G.E. and Evans, W.C., 1972). Due to
the highly potent tumor-promoting property of phorbol myristate acetate (PMA),
the active ingredient of Croton tiglium oil, this drug was considered to be too
toxic for human use and was eventually removed from modem pharmacopoeias
(British Pharmaceutical Codex, 1934) (see Figure 2). This same compound,
PMA, was later found to be a potent protein kinase C activator. This finding is
consistent with the hypothesis that protein kinase C activation is part of the
normal growth control process that becomes perturbed in turnorigenesis
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(Matthews, C. K., Van Holde, K. E., 1997).

Activation of protein kinase C

causes hyperphosphorylation of proteins that control sodium secretion by
intestinal cells. The increased phosphorylation of cytoskeletal or junctional
moieties that regulate solute permeability result in the passive loss of fluids as
diarrhea (Dho et al., 1990).
There are many causes of diarrhea, but the overall alterations in intestinal
function are similar in that the intestine ceases to be an organ of net absorption of
water and electrolytes. The fluid produced exceeds the absorptive capacity of the
remaining intestine and water passes into the stool. The aim of diarrhea treatment
is to enhance intestinal absorption of water by reducing the content of luminal
electrolytes (by increasing active absorption of Na+ or decreasing secretion of
anions). Absorption of fluid by the colon is secondary to active transport of Na+
(Sellin, J. H., 1993).
The mechanism responsible for colonic absorption of Na+ is primarily
electrogenic transport, which relies on a Na+/K+/ATPase activity in the basolateral
membrane of the colonic epithelium. Neutral absorption of NaCl may also be
involved. The colon absorbs

er by an electrically neutral mechanism that

involves the exchange of er for HC03- and by neutral uptake of NaCl. Agents
that elevate intracellular cAMP in colonic enterocytes stimulate electrogenic
secretion of er and may inhibit NaCl uptake. This causes net fluid secretion. The
colon also secretes K+, probably via an active mechanism that is stimulated by
cAMP (Goodman & Gilman, 1996).
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Most animal cells maintain large ionic gradients across their surface
membranes such that intracellular fluid contains a higher concentration of K+
ions and low concentration of Na+ and Ca2+ ions relative to the extracellular fluid.
These ionic gradients are maintained by the action of specific energy-dependent
ion pumps. Ion channels mediating electrical signaling are intrinsic membrane
proteins that form ion-selective pores through which ions can move down their
electrochemical gradients into or out of cells. The responsiveness of voltagegated ion channels to membrane potential is regulated by G-protein-coupled
receptors (Fine, K. D. et al., 1993). These regulatory processes are crucial in the
control of hormone secretion, neurotransmitter release, muscle contraction, and
gene transcription. Both direct binding of G proteins and phosphorylation of the
ion-channel proteins are important effectors of this second order regulation of ionchannel function (Matthews, C. K., Van Holde, K. E., 1997).
Cholera toxin, a highly cathartic peptide produced by Vibrio cholerae, has
been shown to stimulate er secretion in the small intestine and the colon by its
ability to activate adenylate cyclase in the mucosa. The toxin consists of an A
subunit surrounded by five B subunits. The B subunits attach the toxin to
ganglioside GM 1 on the cell surface. The A subunit catalyzes ADP-ribosylation
of the a-subunit of G proteins, reducing GTPase activity. Activating the asubunit of G proteins also catalyzes ADP-ribosylation of cell membrane adenylate
cyclase (Chandana, S. et al., 2001). This activation interferes with the role of the
Ga-subunit in regulating the maintenance of epithelial cell tight junctions. Tight
junctions serve two functions: regulation of the permeability barrier to
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paracellular fluxes, and separation of the apical and basolateral membrane
domains. Loss of regulation of epithelial cell tight junctions results in secretion of
Cl- in the small intestine and colon, causing net fluid secretion (Wang, W. et al. ,
2000).
Research into diarrhetic shellfish poisoning has also contributed to the
understanding of the mechanism of action of cathartic drugs. Diarrhetic shellfish
poisoning (DSP) is caused by consumption of shellfish which have been
contaminated with natural toxins produced by dinoflagellates. The onset of the
illness ranges from 30 minutes to several hours after consumption of the
contaminated shellfish, but seldom exceeds 12 hours (Van Egmond et al. , 1993).
Victims suffer from diarrhea, nausea, and stomach pain, but recover within three
days without serious after-effects. DSP toxins accumulated in the shellfish
inhibit the activity of serine/threonine specific protein phosphatases 1 and 2A in
colonic endothelial cells, resulting in rapid accumulation of phosphorylated
proteins. This rapid accumulation of phosphorylated proteins results in disruption
of the maintenance of electrolyte balance, preservation of membrane potential,
and control of cellular volume in tissues. Oral ingestion of one microgram of
okadaic acid is sufficient to produce the diarrhetic effect in a human being.
Both protein phosphatase 1 (PP 1) and protein phosphatase 2A
(PP2A) are the intracellular targets for the toxins produced by marine organisms
that cause diarrhetic shellfish poisoning. These DSP toxins include the
polyketide inhibitors okadaic acid and dinophysistoxin-4 which are produced by
dinoflagellates. Other natural protein phosphatase inhibitors include cyclic
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peptide inhibitors such as microcystins and nodularins, as well as calyculin and
tautomycin (Gupta et al., 1997). The toxins, though structurally dissimilar from
one another, all seem to bind at the active site of each phosphatase, where they
contact multiple residues near the active site (Suganuma et al., 1989). A free
carboxyl and hydroxyl group in the molecule is essential for receptor binding in
the case of okadaic acid (see Figure 3). These moieties are important for such
compounds to bind to a receptorial site on PP 1 and PP2A, thus inhibiting their
activity and interfering with signal transduction processes, including ion channel
regulation (Sasaki, K. et al., 1994).
These toxins have become important research tools for understanding the
roles of PPl and PP2A in signal transduction.

There are two types of

serine/threonine-specific protein phosphatases: type 1 & type 2 (Ingebritsen &
Cohen). Type 1 protein phosphatases specifically dephosphorylate the

~

subunit

of phosphorylase kinase and are inhibited by nM concentrations of inhibitor-I
(I-1) & inhibitor-2 (l-2), two small heat- and acid- stable proteins found in liver &
muscle extracts, as well as okadaic acid, calyculin A, NaF, and orthovanadate.
A number of different forms of type- I protein phosphatase have been
characterized. They differ in their association with regulatory components, which
determine their overall activity and subcellular location. Additionally, these
forms differ in their substrate specificity measured in vitro using various
phosphoproteins.
Type 2 protein phosphatases preferentially dephosphorylate the a subunit
of phosphorylase kinase & are insensitive to Inhibitor-I and Inhibitor-2. Type 2
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protein phosphatases are subclassified into three distinct enzymes, PP2A, PP2B
and PP2C, which are characterized by their cation dependence and use of various
activators and inhibitors (Cohen, P., 1989).
PPl holoenzymes are heterodimers composed of catalytic PPlc and a
regulatory R subunit. The diverse functions of PP2A are attributed to the
presence of at least 15 B regulatory subunits that individually assemble with each
core heterodimer of PP2Ac and a 65-kDa A subunit. PP2A exists in either
heterodirner or heterotrimer form (Catterall, W. A. , 1997).
As the diarrheic effect of okadaic acid and related toxins has been
attributed to the accumulation of phosphorylated proteins that control sodium
secretion in intestinal cells, a detection method for such cathartic compounds
based on the inhibition of protein phosphatases is of particular interest. Using the
specific inhibition of both PPl and PP2A catalytic subunits provides a sensitive
method to detect diarrhetic shellfish poisoning. Recently, a highly sensitive
fluorometric assay for DSP using PP 1 and PP2A was developed in Dr. Y.
Shirnizu' s lab (Shimizu et al. , 1997) and Dr. Vieytes's lab (Vieytes et al. , 1997),
independently of each other. This assay is based on the dephosphorylation of 4methylumbelliferone phosphate (4-MUP), a non-fluorescing compound, to
fluorescent 7-hydroxy-4-methylcoumarin (4-MU), which fluoresces at
approximately 446 nm, by PPl or PP2A (see Figure 4). The substrate exhibits
high substrate efficiencies for PP 1 & PP2A.
After incubation of 4-MUP and purified PPl enzyme in a 96-well
rnicrotiter plate, liberated 4-MU is measured with a fluorescent scanner.
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Inhibition of PP 1 or PP2A by a specific inhibitor, e.g., okadaic acid, is quantified
using the above protocol. The fluorescent inhibition assay involves introducing a
test sample to the enzyme PPl or PP2A and then adding the substrate 4-MUP.
An inhibitory sample will result in a fluorescence reading that is less than a

control known to be free of such inhibitors.
This inhibition assay has advantages over other assays, such as a
radioactive phosphoprotein assay using 32 P ATP or a para-nitrophenyl phosphate
colorimetric assay (pNPP assay), due to the elimination of clean up and the
increase in specificity, sensitivity, precision, rapidness, reproducibility, and
percentage ofrecovery of the 4-MUP assay. A drawback to this assay is that the
commercially available PP2A enzymes which are obtained from human
erythrocytes are very expensive and no recombinant enzymes are available for
PP2A (Baden et al., 1995).
In this study, the 4-MUP assay was used to test the activity of jalapin and

convolvulin, two hydroxy-acid containing resin glycosides from plants of the
Convolvulaceae family, upon PP2A. Jalapin was isolated from roots of

Ipomoea purga and convolvulin isolated from seeds of Pharbitis nil. At the
same time other known cathartics whose active components contain hydroxy-acid
moieties were also studied including ricinoleic acid (see Figure 5), isolated from
the oil of Ricinus communis (castor oil), and podophyllotoxin (see Figure 6),
isolated from podophyllum resin. The hydroxy acid moieties of these cathartic
compounds, if released, may bind to a receptorial site on PP2A, as seen with the
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DSP toxins, inhibiting its activity and interfering with signal transduction
processes such as ion channel regulation (Sasaki, K. et al., 1994).
Castor oil is cold-pressed from the seeds of Ricinis communis
(Euphorbiaceae) and has traditionally been taken orally as a stimulant cathartic. It
is composed of a mixture of triglycerides, of which about 7 5 % is triricinolein.
Triricinolein is hydrolyzed by lipases in the duodenum to release ricinoleic acid,
which exerts a cathartic effect (Tyler et al., 1988). Podophyllotoxin is the active
principle of podophyllum resin, also called podophyllin, which is isolated from
the roots of Podophyllum peltatum, Berberidaceae (American Mandrake or
Mayapple). The resin possesses drastic purgative properties and its active
constituents consist of a mixture of lignans including podophyllotoxin (20%), a.peltatin (10%), and

~-peltatin

(5%) (Emmenegger, H. et al., 1961 ).

It has long been known that certain plant species of the Convolvulaceae

family produce drastic cathartic and purgative effects when consumed. Two
species ofthis family, Ipomoea purga (Mexican Jalap), and Pharbitis nil
(Morning Glory), were used in this study. Both of these plants produce resins,
jalapin and convolvulin, respectively, which are both monomers of hydroxy-fatty
acid oligoglycosides in which the sugar moiety is partially acylated by organic
acids and can also combine with the carboxy group of the aglycone to form a
macrocyclic ester in the case of jalapin (Noda, et al, 1987). Studies have
identified these resins to be the active cathartic components of these crude drugs
(Mannich, C. et al., 1938; Shellard, E. J., 1961). Jalapin is characterized by the
presence of an oligoglycoside of 6-deoxyhexoses (rharnnose, fucose), whose
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aglycone is the hydroxylated fatty acid 1 lS-hydroxyhexadecanoic acid or
jalapinolic acid. The aglycone found in convolvulin, also known as pharbitinis
the hydroxy lated fatty acid, 11 S-hydroxytetradecanoic acid or convolvulinic acid
(pharbitic acid) (Ono, 1990).
Jalapin is obtained from the dried tubercles of Convolvulaceae plants,
including Ipomoea purga, which was chosen as the source of jalapin for this
study, as well as I. orizabensis, I. braziliensis, I. simulans, and Convolvulus

scammonia. Convolvulin is obtained from the seeds of Convolvulaceae plants,
including Pharbitis nil, which was chosen as the source of convolvulin for this
study. The plant materials were extracted and the chemical structures of the
isolates were confirmed by proton nuclear magnetic resonance (NMR), prior to
use in the 4-MUP PP2A inhibition assay.
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Figure 1. Anthracene Derivatives Found in Cathartic Plant Drugs
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Figure 2. Structure of Phorbol Myristate Acetate (PMA) from Croton
Oil, Croton tiglium, Euphorbiaceae.
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Figure 3. A Free Carboxyl at Cl and Hydroxyl Groups at C24 and
C27 Are Essential for PP2A Receptor Binding of Okadaic Acid
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Figure 4. 4-MUP Assay
PPl & PP2A Dephosphorylate 4-MUP to 4-MU
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Figure 5. Structure of ricinoleic acid (12-hydroxystearic acid) from
the seeds of Ricinus communis, Euphorbiaceae
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Figure 6. Structure of the lignan podophyllotoxin from the roots of
Podophyllum peltatum, Berberidaceae

17

EXPERIMENTAL
Materials & Methods
Unless otherwise specified, all chemicals were reagent grade or better.
Solvents for extraction, partitioning, and chromatography were HPLC grade.
Distilled deionized water was used to make all solutions needed for the 4-MUP
assay. Deionized water was used for all other procedures.
The following abbreviations have been used in this work:
protein phosphatase 1 (PPI), protein phosphatase 2 (PP2A), protein phosphatase
2B (PP2B), protein phosphatase 2C (PP2C), protein phosphatase 2A catalytic
subunit (PP2Ac), proton nuclear magnetic resonance {1H-NMR), phorbol
myristate acetate (PMA), 4-methylumbelliferyl phosphate (4-MUP), 4methylumbelliferone (4-MU), high pressure liquid chromatography (HPLC), thin
layer chromatography (TLC), protein kinase (PK), adenosine triphosphate (ATP),
adenosine diphosphate (ADP), cyclic adenosine monophosphate (cAMP),
inhibitor-I (I-1 ), inhibitor-2 (1-2), guanosine triphosphate (GTP), diarrhetic
shellfish poisoning (DSP), and hydroxymethyl aminomethane (Tris).
Dried tubercles of lpomoea purga (Mexican jalap root) were purchased
from Trinity Herb Co. (Graton, CA). Seeds of Pharbitis nil (morning glory seeds)
were harvested at the URI Heber Y oungken Medicinal Plant Garden in Kingston,
RI. Ricinoleic acid and podophyllotoxin were purchased from Sigma-Aldrich
Chemical Co. (St. Louis, MO). Okadaic acid was purchased from LC
Laboratories (Woburn, MA). 4-Methylumbelliferyl phosphate (4-MUP) and 4methylumbelliferone (4-MU) were purchased from Molecular Probes, Inc.
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(Eugene, OR). Tris (hydroxymethyl) aminomethane (electrophoresis purity) and
2-mercaptoethanol were obtained from Bio-Rad Laboratories (Richmond, CA).
Protein phosphatase 2A (PP2A) from human red blood cells (purified enzyme)
was purchased from Upstate Biotechnology Inc. (Lake Placid, NY). NMR
solvent pyridine-d5 was purchased from Cambridge Isotopes, Inc. (Andover,
MA). Assorted laboratory glassware, magnesium chloride-6H20, hydrochloric
acid, 1-butanol, chloroform, methanol, and methylene chloride were purchased
from Fisher Scientific Inc. (Fairlawn, NJ). Ethanol was purchased from Aaper
Alcohol, Inc. (Shelbyville, KY). For column chromatography, Baker silica gel
(J. T. Baker, Inc. Phillipsburg, NJ) (40 µm average particle diameter) and Bio-gel
LH-20 (Amersham Pharmacia Biotech, Piscataway, NJ) were used. Thin layer
chromatography plates were purchased from Whatman, Ltd. (Maidstone, Kent,
England).
The following equipment and instruments were employed in this study:
MTX Labsystems, Inc. Titertek Fluoroskan II version 4.0 ofBio-Tek FL500
Fluorescence Reader, Yamato Rotary Evaporator model RE-46 with water bath
model BM-41 , Amsco Autoclave, Eppendorf micropipettors, Dell Latitude C600
Laptop computer, Fuji Digital Camera, HP Scanjet 5200C Color Scanner, Fisher
Vortex Genie 2, Sonicor Ultrasonic Cavitator, Precision Scientific Co. Vaccuum
Pump model S-35 and Vacuum Dessicator, Fisher Scientific Accumet 15 pH
meter, and VMR I 550 Incubator from VMR Scientific. Microsoft Excel t-test
was used to determine P values.
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Nuclear Magnetic Resonance (NMR) Spectroscopy
Nuclear Magnetic Resonance (NMR) spectrum of 1H-NMR was recorded on the
Bruker Model DPX-400 Avance NMR spectrometer, College of Pharmacy,
University of Rhode Island. Data processing was performed with the standard
software by Silicon Graphics Indy Station NMR Analysis and Dell 450MHz NT
Workstation NMR Analysis Computer. Five milligrams of each sample was
dissolved respectively in HPLC grade methanol, filtered through non-adsorbant
cotton, and dried under the flush of nitrogen gas and further subjected to vacuum
desiccation. The dried samples were each dissolved in 0.6 ml pyridine-d5
(Cambridge Isotopes, Inc.) to take 1H-NMR spectrum.

Thin Layer Chromatography (TLC)
TLC was performed on silica-gel coated aluminum sheets and silica-gel coated
glass plates using developing solvent CHCh:MeOH:H20 (6:4:1). Resin
glycosides such as jalapins and convolvulins lack UV absorbance, so in order to
visualize the compounds on TLC plates. The vanillin/sulfuric acid spray reagent
(3.0 g vanillin, 40 ml glacial acetic acid, 30 ml concentrated sulfuric acid, and
450 ml 95% ethanol) was used, followed by heating on a hot stage.

Extraction of Ipomoea purga Roots
Extraction and fractionation were generally based on the methods of Ono

et al. (1990). The outline of the extraction is shown in Figure 12. Fifty grams of
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root tubercles of lpomoea purga were pounded into a powder and macerated in
methanol, sonicated, and extracted three times at room temperature, each time 200
ml methanol was used. Each methanol extraction was suctioned-filtered through
a Buchner funnel lined with filter paper into a filtration flask, giving an orangecolored solution. The three filtered methanol extracts were combined and
evaporated to dryness with a rotary evaporator, yielding a golden-orange resin
(6.15 grams). Two grams of this methanol extractive was suspended in 25 ml of
water in a separatory funnel and extracted three times with 1-butanol, each time
25 ml 1-butanol was used. The aqueous layer was a yellow color and was
evaporated with a rotary evaporator to give a yellowish resin (330 milligrams).
The three 1-butanol extracts were orange in color and were combined together,
then evaporated in a rotary evaporator to give a golden-orange resin (l.65
grams). This 1-butanol extractive was defatted with methylene chloride three
times, each time using 25 ml of methylene chloride. The three methylene
chloride extracts were combined and evaporated with a rotary evaporator to yield
a yellow oil (100 milligrams). The defatted 1- butanol-soluble extractive ( 1.55
grams) was further purified by liquid chromatography.

Purification of I. purga Resin Glycosides by Liquid Chromatography
a. Silica Gel Column Chromatography of Defatted 1-Butanol-soluble Extractive
Twenty-five grams of silica gel was suspended in chloroform:methanol
solution (10: 1) and then immediately and continuously poured into a 2 cm
diameter glass chromatography column. After the silica gel settled down and
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there was barely any chloroform:methanol solution left above the surface of the
silica gel, the defatted 1-butanol soluble extract (630 mg of 1.55 grams) was
dissolved in the chloroform:methanol solution (10: 1) and loaded. The column
was eluted with chloroform and methanol in 60 ml quantities in which the
percentage of methanol was increased stepwise with the following ratios of
chloroform to methanol: 10:1, 5:1, 5:2, 5:3, and 5:4. Fractions were collected in
4 ml aliquots and each fraction was checked by TLC. Fractions containing the
same components were combined based on TLC results.

Extraction of Pharbitis nil Seeds
Extraction and fractionation were generally based on the methods of Ono
et al. (1990) as previously described. The outline of the extraction is shown in

Figure 13. One hundred grams of seeds of Pharbitis nil were ground into a
powder and used as starting materials for the extraction. The methanol extraction
produced a yellow resin (4.17 grams). After partitioning 2.00 g of this methanol
extractive between water and 1-butanol, 0.73 grams of water-soluble extract and
1.26 grams of 1-butanol soluble material were obtained.

This 1-butanol extract

was defatted with methylene chloride, as described previously, to yield a yellow
oil (1.21 grams). The remaining defatted 1-butanol extract was evaporated with
rotary evaporator and weighed 50 milligrams. Both the water-soluble extract and
the defatted 1-butanol extract were further purified by liquid chromatography.
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Isolation of P. nil Resin Glycosides by Liquid Chromatography
a. Silica Gel Column Chromatography of Water-soluble Extract
Twenty-five grams of Baker silica gel was suspended in
chloroform:methanol:water solution (6:4: 1) and then immediately and
continuously poured into a 2.25 cm diameter glass chromatography column to a
height of 20 cm. The water- soluble extract (700 mg of 730mg) was dissolved in
chloroform:methanol:water solution (6:4: 1) and loaded onto the silica gel column,
using just enough solution to dissolve the sample. The column was eluted with
the chloroform:methanol:water solution (6:4: 1). Fractions were collected in 10
ml aliquots and each fraction was checked by TLC. Fractions containing the
same components were combined based on TLC results.

b. LH-20 Biogel Column Chromatography ofDefatted 1-Butanol-soluble Extract
A 1.5 cm diameter glass chromatography column was packed to a height
of 14 cm with Bio-gel LH-20 previously suspended in methanol. After the LH-20
settled down and there was barely any methanol left above the top of the gel, the
defatted 1-butanol extract (50 mg) dissolved in methanol was loaded. The
column was eluted with methanol. Fractions were collected in 3 ml aliquots and
each fraction was checked by TLC. Fractions containing the same components
were combined based on TLC results.
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Standard Emission Curve of 4-Methylumbelliferone (4-MU)
One 10 µM 4-MU stock solution and one 5 µM 4-MU stock solution were
made by dissolving 0.00018 grams and 0.00009 grams of 4-MU, respectively, in
100 ml of Tris buffer which was made of 50 mM, 20 mM MgC}i, and 1 mM 2mercaptoethanol, pH 8.5 adjusted with 1N HCL Serial dilutions were made by 50
mM Tris buffer, pH 8.50 to make concentrations of 10, 5, 1, 0.5, 0.1, 0.05, 0.01,

0.005, 0.001, 0.0005, and 0 µM. Fifty microliters of each solution was pipetted
into each well used, on a 96-well microtiter plate. Each row consisted of six
replicates of the given concentration for that column. In total, sixty-six wells
were filled on the plate, which was read on the Fluoroskan II, version 4.0 of
Biotek FL500 Fluorescence Reader at time zero and time 30 minutes.

Preparation of Tris Buffer, pH 8.50 [50 mM]
Tris (3.04 grams) and MgC}i.6H20 (2.04 grams), were weighed and
combined in a 500 ml glass beaker which was filled to the 400 ml mark with
distilled, deionized water, and 2-mercaptoethanol (36 µl) was added. The pH of
the solution was adjusted to 8.50 with 1 N hydrochloric acid. The contents of the
beaker were transferred to a 500 ml volumetric flask. The beaker was rinsed with
100 ml of distilled, deionized water, which was added to the 500 ml volumetric
flask. The flask was capped and inverted several times. The concentration of the
Tris buffer was 50 mM.
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Preparation of 4-MUP Solution, pH 8.50 [50 mM]
4-MUP (6.36 milligrams), was added to 250 ml 50 mM Tris buffer, pH
8.50.
Preparation of Test Solutions of Plant Extracts for 4-MUP Assay
Each of the plant samples isolated in this experiment, jalapin and
convolvulin, were dissolved in 500 µl of methanol and combined with 9.5 ml of
50 mM Tris buffer, pH 8.50. From these 5% methanolic solutions, serial dilutions
were prepared using the Tris buffer. The ricinoleic acid and podophyllotoxin
samples were also prepared in serial dilutions, but starting with a 1% methanolic
solution. The PP2A 4-MUP inhibition assay is sensitive to alcohol in
concentrations of 5% or greater in the total well concentration.

One percent

methanol was the highest concentration of methanol in any of the 50 µl wells of
the microtiter plates used in this experiment.
Jalapin (15 .9 milligrams) was added to a small vial containing 500 µl of
methanol and sonicated until completely dissolved. Into this vial, 9 .5 ml of 50
mM Tris buffer, pH 8.50, was pipetted to give the jalapin solution a concentration

of 1.59 mg/ml. Three serial dilutions were made by taking one milliliter of this
1.59 mg/ml solution and pipetting it into nine milliliters of 50 mM Tris buffer, pH
8.50. Each newly prepared dilution was used in place of the stock solution used
before it. The concentrations of the jalapin samples made were 1.59 mg/ml, 0.159
mg/ml, 0.0159 mg/ml, and 0.00159 mg/ml, respectively.
Convolvulin (14.81 milligrams) was added to a small vial containing 500
µl of methanol and sonicated until completely dissolved. Into this vial, 9.5 ml of
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50 mM Tris buffer, pH 8.50, was pipetted to give the convolvulin solution a
concentration of 1.48 mg/ml. Three serial dilutions were made starting with the
1.48 mg/ml convolvulin solution. The concentrations of the convolvulin solutions
made were 1.48 mg/ml, 0.148 mg/ml, 0.0148 mg/ml, and 0.00148 mg/ml.
Ricinoleic acid (100 mg) was pipetted into a small vial containing one
milliliter of methanol to give a 100 mM concentration of ricinoleic acid. Into a
small vial containing 900 µl of methanol, 100 µl of 100 mM ricinoleic acid
solution was pipetted, to make a 10 mM concentration of ricinoleic acid. One
hundred micro liters of 10 mM ricinoleic acid solution was pipetted into a small
vial containing 900 µl of 50 mM Tris buffer, pH 8.50, to make a 1 mM
concentration of ricinoleic acid, containing ten percent methanol. Three more
serial dilutions were made, starting with the 1 mM ricinoleic acid solution. These
three serial dilutions were diluted with 900 µl of 50 mM Tris buffer, pH 8.50,
instead of 900 µl of methanol. The concentrations of these ricinoleic acid
solutions were 100 µM, 10 µM , and 1 µM , respectively.
Podophyllotoxin (4.14 milligrams) was pipetted into a small vial
containing 1 ml of methanol to make a 10 mM solution. One hundred micro liters
of 10 mM podophyllotoxin solution was pipetted into 900 µl of 50 mM Tris
buffer, pH 8.50, to make a podophyllotoxin solution with a 1 mM concentration
that contained ten percent methanol. Three more serial dilutions were made
starting with the 1 mM podophyllotoxin solution. These three serial dilutions
were diluted with 900 µl of 50 mM Tris buffer, pH 8.50. The concentrations of
these podophyllotoxin solutions were 100 µM , 10 µM , and 1 µM, respectively.
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4-Methylumbelliferone Phosphate Fluorometric Assay (4-MUP Assay)
In a 96-well microtiter plate, placed on ice, l µl of purified PP2A enzyme
from Upstate Biotechnology was added to 10 µl of the compound being tested for
potential inhibitory activity. The concentration of purified PP2A enzyme was
0.03 units per well. The mixture of the potential inhibitory compound with the
enzyme was incubated at room temperature on a 3-D rotator (Lab-Line
Instruments, Inc., Melrose Park, IL) for five minutes before adding the substrate.
Thirty-nine microliters of the substrate, 50 mM 4-MUP in 50 mM Tris buffer (20
mM MgCh, and 1 mM 2-mercaptoethanol, pH 8.5 adjusted with 1N HCl), was
added to each well to make a total volume of 50 µl per well. Each row of wells
on the plate consisted of six replicates of the given reaction mixture for that row.
Fluorescence intensity measurements were performed using ICN Titertek model
Fluoroskan II fluorescence reader using ex. 355 nm I em. 460 nm filters.
Readings were taken at time zero, thirty, and sixty minutes, after incubating the
reaction mixtures at 37 °C. Inhibition of PP2A by a specific inhibitor, i.e. okadaic
acid, was quantified using the above protocol. Four 96-well microtiter plates
were used in this experiment.
Okadaic acid was used as a reference inhibitor on each of the four
microtiter plates used. The okadaic acid sample was previously prepared in Dr.
Shimizu's lab by Dr. X. Qu, in a 60 nM concentration. A 60 nM concentration of
okadaic acid is known to completely inhibit the activity of PP2A (X. Qu, 1998).
Each plate contained a row of wells with 60 nM okadaic acid in the presence of
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the PP2A enzyme and 4-MUP substrate. Each plate also contained a row of
control wells with 60 nM okadaic acid in the presence of the substrate with no
enzyme. In the row of control wells with no enzyme, the wells were filled with 1
µl of 50 rnM Tris buffer, pH 8.50, in place of the 1 µl of PP2A enzyme.
Each microtiter plate was used to test the potential inhibitory activity of
each of the following compounds on PP2A, respectively: jalapin (plate 1),
convolvulin (plate 2), ricinoleic acid (plate 3) and podophyllotoxin (plate 4).
Each row of wells to be filled on the plate, consisted of six replicates of the given
concentration of compounds to be tested. Each microtiter plate also had a row of
control wells which contained 39 µl of 4-MUP substrate in the presence of 1 µl of
PP2A enzyme, without any inhibitory compound being present. These control
wells were filled with 10 µl of 50 rnM Tris buffer, pH 8.50, in place of any
potential inhibitory compounds.
Plates 1 and 2 tested four concentrations of jalapin and convolvulin,
respectively, for their inhibitory effects on PP2A. Plates 3 and 4 tested three
concentrations of ricinoleic acid and podophyllotoxin, respectively, for their
inhibitory effects on PP2A. For each concentration of compound tested on each
plate, there was a row of control wells filled on the same plate containing the
same concentraton of compound being tested, but in the presence of the 4-MUP
substrate without any PP2A enzyme. In the rows of wells containing no enzyme,
the wells were filled with 1 µl of 50 rnM Tris buffer, pH 8.50, in place of the 1 µl
of PP2A enzyme.
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RESULTS AND DISCUSSION
A schematic representation of the extraction and isolation of jalapin from

Ipomoea purga roots is shown in Figure 7. Several purple spots were observed on
silica-gel TLC of the 1-butanol-soluble portion of the methanol extract of the
I. purga roots (1.65 grams). This 1-butanol extract was separated by silica-gel

chromatography to afford a crude glycoside mixture. The fractions did not have
color, had no UV absorbance, and displayed a purple color after being sprayed
with the vanillin/sulfuric acid reagent. One of the TLC plates is shown in Figure
14. These fractions were further identified by 1H NMR. The total weight of the
two samples identified by 1H NMR was 279 milligrams (14% of crude methanol
extract) and 186 milligrams (9% of crude methanol extract). These fractions were
combined prior to the assay. These two fractions, each appearing as a single
bluish-purple spot, had Rf values of0.71 and 0.75. These normal phase Rf values
are reasonable values for high molecular weight amphoteric resin glycosides
containing lipophilic fatty acids and hydrophilic sugar moieties.
Based on their 1H NMR spectra, these samples were determined to contain
a mixture ofhomologues or very closely related compounds. Variations in the
structures of these resin glycosides primarily come from the differing organic acid
moieties such as tiglic acid, isobutyric acid, etc. which can occur. Variations also
occur due to the different types and numbers of sugars within the glycosides.
However, these resin glycosides do share a basic structure which includes the
hydroxy-acid moieties. The percentages of these resin glycosides present in the
total crude extract are exceptionally high, reaching up to 26.9% of the crude
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methanol extract in some Convolvulaceae species (Noda, N., 1987 ). The
predominance of these resin glycosides in the crude extract may account for the
1

H NMR data fitting the molecular structure so well, despite the fact that the

separation procedure was not so thorough.
The 1H NMR spectra of these two fractions were identical (Figure 10) and
gave similar 1H NMR spectra as those compared to in the literature (H. Kogetsu et
al., 1991 ), based on the peak assignments, integration, and ratios of hydrocarbon

protons to protons of sugar and organic acids. This suggests that the resin
glycosides are similar to what Mayer called the ether-soluble resin glycosides
(Shellard, 1961). The 1H NMR showed three acetoxy methyl signals [8 1.96
(8H), 2.34 (2H), 2.69 (2H)], the signals characteristic of 1 mol of isobutyric acid

[8 2.92, (1 H, sept, H-2), 1.21 (3H, d, H3-3), 1.07 (3H, d, H3-3')] and 2 mols of
tiglic acid groups [8 7.02 (lH, dq, H-3), 1.59 (3H, dd, H3-5), 1.82 (3H, s, H 3-4)]
and [8 7.17 (lH,dq, H-3), ), 1.36 (3H, dd, H3-5), 1.65 (3H, s, H3-4)]. The 1H
NMR spectrum showed five anomeric protons

(8 5.51, 5.13, 4.82, 5.67 and 4.81)

and four secondary methyls due to 6-deoxyhexose (8 1.56, 1.26, 1.45 and 1.65) as
well as a 2-methylene (8 2.69) and a primary methyl (8 0.96) attributable to a
jalapinolic acid moiety (Table 1). Based on this data, it is reasonable to presume
that the Ipomoea resin glycoside isolated in this experiment is similar to the
proposed chemical structure depicted in Figure 11.
A schematic representation of the extraction and isolation of convolvulin
from Pharbitis nil seeds is shown in Figure 8. The crude methanol extract
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obtained from 100 grams of seeds weighed 4.17 grams. After partitioning 2.0
grams of this crude extract between 1-butanol and water, the amount ofwatersoluble extract was 730 milligrams (36.5 % of crude methanol extract). The
amount of 1-butanol-soluble extract was 50 milligrams (2.5 % of crude methanol
extract). These fractions had a slight yellowish-white color and had no UV
absorbance. The water-soluble portion of the methanol extract from Pharbitis nil
seeds exhibited several brownish-gold spots on silica-gel TLC. The LH-20 biogel
column chromatography was employed to separate them. However these further
purified fractions obtained from the chromatography were found to be pure sugars
of di- and oligo-saccharides based on their 1H NMR spectra, indicating that the
convolvulinic acid aglycone had been hydrolyzed from the sugars and remained
in the column. For this reason, the crude extracts obtained after the partitioning
were identified by 1H NMR and employed to run the PP2A 4-MUP inhibition
assay. Two fractions, one being water-soluble and the other 1-butanol-soluble,
each appeared as a group of three spots and had identical Rf values of 0.08, 0.14,
and 0.32 (see Figure 12). These normal phase Rf values are reasonable values for
high molecular weight amphoteric water-soluble resin glycosides containing
lipophilic fatty acid and hydrophilic sugar moieties. Since the carboxy group of
the aglycone (convolvulinic acid) is free and does not combine with a hydroxy
group of the sugar moiety to form an intramolecular macrocyclic ester structure,
as seen in Ipomoea purga resin glycosides, there are more free hydroxyl groups
present, contributing to the water-soluble property of these resin glycosides (Ono,
M. et al., 1990). Due to not being chromatographed, the purities of these samples
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were crude compared with the lpomoea purga samples. Based on the data from
the 1H NMR spectra, it was determined that they contained the resin glycosides
as a mixture of homologues. It is possible that other contaminants may have
been present, since many glycolipids were isolated in the extraction process.
Although the Pharbitis nil samples were rather crude preparations, their
1

H NMR spectra (Figure 13) gave similar 1H NMR spectra as those compared to

in the literature, based on the peak assignments, integration, and ratios of
hydrocarbon protons to protons of sugar and organic acids. Again this suggests
that the resin glycoside was an overwhelmingly major component in these
samples. They are similar to what Mayer called ether-insoluble resin glycosides
with a free carboxy group of the convolulinic acid aglycone (Shellard, 1961 ).
These suggestions were supported by the presence in the 1H NMR of the signals
characteristic of 1 mol of isobutyric acid

[O 2.55, (1 H, sept, H-2), 1.27 (3H, d,

H3-3), 1.27 (3H, d, H3-3')], 2 mols of (+)-2-methylbutyric acid

[O 2.53 (lH,tq, H-

2), ), 1.69 (2H, m, H3-3), 0.99 (3H, s, H3-4), 1.27 (3H, d, H3-5) and

[O 2.43

(IH,tq, H-2), ), 1.60 (2H, m, H3-3), 0.94 (3H, s, H3-4), 1.27 (3H, d, H3-5)] and 1
mol oftiglic acid groups

[O 7.01 (IH, dq, H-3), 1.27 (3H, dd, H3-5), 1.93 (3H, s,

H3-4)]. The 1H NMR spectrum exhibited the signals of five anomeric protons (0
6.32, 5.85, 5.48, 5.30 and 4.89) and three secondary methyls due to 6deoxyhexose (O 1.93, 1.67 and 1.63) as well as a 2-methylene

(O 2.55) and a

primary methyl (0 0.87) attributable to a convolvulinic acid moiety (see Table 2).
Based on this data, it is reasonable to presume that the Pharbitis resin glycoside
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isolated in this experiment is similar to the proposed chemical structure depicted
in Figure 14.
In the assay experiments, the standard emission curve of 4-MU was

established (Figure 15). The fluorescence intensity of 4-MU was in a linear
function with its concentration in the experimental range (0 to 10 µM). The
enzyme activity could be analyzed by using the standard emission curve to
compare the amount of 4-MU from the dephosphorylation of 4-MUP by PP2A.
The okadaic acid at 60 nM was used as a reference inhibitor to verify that
the enzyme inhibition assay was working correctly. The results showed at least
99% significant inhibition of PP2A by 60 nM okadaic acid on all four plates, with
the largest p value of the four sets of okadaic acid data being less than 0.01.
These results were expected since 60 nM of okadaic acid is a known
concentration to completely inhibit PP2A activity. For each row of compounds
tested on PP2A on each microtiter plate, a duplicate row of controls wells was
prepared on the same plate that contained 1 µl of Tris buffer, pH 8.50 in place of
the 1 µl of PP2A enzyme. These controls indicated that none of the compounds
tested in this assay fluoresced on their own and therefore quenching could not
occur that might produce false results. The row of control wells on each plate
that contained 1 µl of PP2A enzyme, 39 µl of 4-MUP and 10 µl of Tris buffer, pH
8.50 was used to determine the normal activity that would be expected from the
enzyme with no other compounds present. All of the wells on each plate
containing potential inhibitory compounds were compared against these
respective control wells to observe any change in activity of the enzyme.
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The jalapin samples tested against PP2A were prepared in the following
concentrations: 1.59 mg/ml, 0.159 mg/ml, 0.0159 mg/ml, and 0.00159 mg/ml.
These concentrations would correspond to 1 mM, 100 µM , 10 µM , and 1 µM if
the samples were pure, according to the molecular weight of the proposed
structure of the glycoside. Similarly, the convolvulin samples were prepared in
the following concentrations: 1.48 mg/ml, 0.148 mg/ml, 0.0148 mg/ml, and
0.00148 mg/ml, which, likewise, would correspond to 1 mM, 100 µM , 10 µM ,
and 1 µM of pure glycoside. The molecular weight of the proposed jalapin
structure is 1,590 and the molecular weight of the proposed convolvulin structure
is 1, 480.
The results of the inhibition assays are shown in Figures 21 - 24.

A 4%

increase in activation occurred at the 1.59 mg/ml concentration of jalapin,
however the p value was equal to 0.3, so this data should be considered to be
insignificant. Whereas, 12 % inhibition was observed at the concentrations of
0.159 mg/ml and 0.0159 mg/ml, with the p values both less than 0.01. The jalapin
samples showed a maximum inhibition of 20% at the 0.00159 mg/ml
concentration with a p value, 0.04. (see Figure 16). According to this data, the
activity of PP2A did not change when the concentration of jalapin was decreased
ten-fold from 0.159 mg/ml to 0.0159 mg/ml. The PP2A inhibition increased
when the concentration ofjalapin was decreased ten-fold from 0.0159 mg/ml to
0.00159 mg/ml. However, the data from the 1.59 mg/ml concentration of jalapin
was not significant, and there was no observable trend for the inhibition to
increase as the concentration of jalapin decreased. The effective dose of jalapin
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(as a powdered resin) consumed orally which will produce catharsis is 2 grams
(see Table 3). Because of the six order difference between the effective dose and
the 0.00159 mg/ml concentration of jalapin which caused 20 % inhibition of
PP2A in vitro, the possibility can not be excluded that jalapin inhibits PP2A .
The convolvulin showed a maximum inhibition of 50.9 % at the 1.48
mg/ml concentration with a p value less than 0.01, 5.7 % inhibition at the 0.148
mg/ml concentration with a p value of 0.045, 15.5 % inhibition at the 0.0148
mg/ml concentration with a p value of0.12, and 8% increase in enzyme activity
occurred at the 0.00148 mg/ml convolvulin concentration with a p value less than
0.01 (see Figure 17). The inhibition of PP2A activity was significantly increased
by 45.2% when the concentration of convolvulin was increased ten-fold from
0.148 to 1.48 mg/ml, increasing the inhibition from 5.7 % to 50.9 %. This was
the largest significant change observed among two concentrations of the same
compound with a ten-fold difference in concentration, out of the four cathartic
plant drugs tested with this assay. The 15 .5 % inhibition of PP2A activity
reported for the 0.0148 mg/ml concentration of convolvulin should not be
considered significant based on the 0.12 p-value. An 8% increase in activation
occurred at the 0.00148 mg/ml concentration of convolvulin. This does not seem
to be consistent with the rest of the convolvulin data, despite the data's
significance due to the low p-value below 0.01. The effective dose of convolvulin
(as a powdered resin) consumed orally to produce catharsis is 2 grams (see Table
3). Because of the three order difference between the effective dose and the 1.48
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mg/ml concentration of convolvulin which caused 50.9 % inhibition of PP2A in
vitro, the possibility can not be excluded that convolvulin may inhibit PP2A .
The ricinoleic acid samples showed a maximum of 9. 7 % inhibition of
enzyme activity at the 100 µM ricinoleic acid concentration with a p value of
0.02, a 6. 7 % inhibition at 10 µM with a p value of 0.01, and a 0.04 % inhibition
of enzyme activity occurred at the 1 µM ricinoleic acid concentration with a p
value less than 0.01 (see Figure 18). This data is significant, therefore ricinoleic
acid may have a weak inhibitory effect on PP2A. According to this data, there
was a slight trend for the inhibition of PP2A to increase as the concentration of
ricinoleic acid increased. The effective dose of ricinoleic acid (as castor oil)
consumed orally which will produce catharsis is 30 milliliters (see Table 3).
Because of the substantial difference between the effective dose and the
concentration of ricinoleic acid which caused 9.7 % inhibition of PP2A in vitro,
the possibility can not be excluded that ricinoleic acid may inhibit PP2A .
The podophyllotoxin samples showed a maximum inhibition of 7.2% at
the 100 µM concentration with a p value of 0.03. There is 97% confidence that
this data is significant, so podophyllotoxin may have a weak inhibitory effect on
PP2A. A 3.4 % increase in activation occurred at the 10 µM concentration of
podophyllotoxin, whereas the 1 µM concentrations showed an inhibition of 5.6 %
PP2A activity (see Figure 19). However, these values should not be considered
significant since there is only 15% and 25% confidence in this data based on the p
values. Therefore it is unclear whether the inhibition is increasing or decreasing
as the concentration of podophyllotoxin increases. The effective dose of
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podophyllotoxin consumed orally which will produce catharsis is 1.25 grams (see
Table 3). Since there is a four-order difference between the effective dose and the
concentration of podophyllotoxin which caused 7.2 % inhibition of PP2A in vitro,
the possibility can not be excluded that podophyllotoxin may inhibit PP2A.

The cathartic compounds studied were chosen because of their partial
structural resemblance to the DSP toxin okadaic acid and its derivatives. Their
structural resemblance may cause them to act in the same manner as okadaic acid.
These plant-derived compounds all contain unique hydroxy acid moieties which
can be easily cleaved in the intestines to produce catharsis.

Although okadaic

acid and its derivatives have complicated structures, the functional groups
essential for binding to protein phosphatase 1 and 2A have been determined to be
a carboxyl group and hydroxyl groups. They are located on the straight-chain
carbon-carbon backbone. With the folding of the molecule, a free carboxyl group
at carbon one and free hydroxyl groups at carbons 24 and 27 become available
and are essential for receptor binding in the case of okadaic acid (see Figure 3).
This was determined by x-ray crystallography of okadaic acid bound to the
protein phosphatase 1 and 2A enzymes (Sasaki, K. et al., 1994). These moieties
are important for such compounds to bind to a receptorial site on protein
phosphatases 1 (PPl) and 2A (PP2A), thus inhibiting their activity and interfering
with signal transduction processes, such as ion channel regulation. The loss of
ion channel regulation results in the efflux of electrolytes and water as diarrhea.

37

Resin glycosides are well known as the purgative ingredients of some
crude drugs such as Pharbitidis Semen and Jalapae Tuber which originate from
Convolvulaceae plants. Chemical investigations on these resin glycosides were
conducted as early as 1840 by J. F. W. Johnston. When these resin glycosides are
subjected to alkaline hydrolysis, a hydroxyfatty acid oligoglycoside (glycosidic
acid) and some organic acids (isobutyric, 2-methylbutyric, tiglic acids, etc.) are
provided. The glycosidic acid is cleaved by acid hydrolysis to yield a
hydroxyfatty acid and several kinds of monosaccharides such as glucose
rhamnose, quinovose, etc. (Noda, N. et al. , 1987).
Jalapae Tuber, the dried sliced root of Ipomoea purga, a Convolvulaceae
species indigenous to Mexico, is well known as a purgative crude drug. The resin
obtained from the root is called Ipomoea resin. Its resin glycoside is typically
known as Mayer's "jalapin", an ether-soluble resin glycoside (Mayer, W. , 1852).
The hydroxyfatty acid (jalapinolic acid) obtained by alkaline and subsequent acid
hydrolyses of Ipomoea resin was determined to be 11-hydroxyhexadecanoic acid
(Asahina, Y. et al. , 1922). In 1961 , Shellard reexamined the components of this
resin and identified seven organic acids (acetic, propionic, isobutyric, tiglic, 2methylbutyric, n-valeric and isovaleric acids), three sugars (glucose, fucose, and
rhamnose) together with the jalapinolic acid from the ether-soluble portion. The
same organic acids and sugars were isolated from the ether-insoluble portion
along with ipurolic and convolvulinic acids. The parent glycosides were not
isolated.
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Pharbitidis Semen, the seeds of Pharbitis nil, a species of morning glory,
is a cathartic crude drug. Its resin glycoside is typically known to be a Mayer' s
"convolvulin," an ether-insoluble resin glycoside (Mayer, W., 1852). Early
chemical investigations on the resin glycoside of this plant revealed the presence
of a hydroxytetradecanoic acid (convolvulinic acid) and tiglic acid (named for

Croton tiglium, the source from which it was initially isolated), along with a
glycosidic acid by alkaline hydrolysis and two crystalline fatty acids and Dglucose by acid hydrolysis of the glycosidic acid. (Kromer, N., 1896). More
detailed investigations were later reported that alkaline hydrolysis of the crude
glycoside named pharbitin (convolvulin) gave an organic acid named nilic acid
(2-methyl-3-hydroxybutyric acid), together with tiglic acid and (+)-2methylbutyric acid (Asahina Y. et al. , 1922). Mannich and Schumann in 1938
presumed Mayer' s "convolvulin" to be a complex glycoside composed of a
number of the repeating unit which is a glycosidic acid partially acylated by some
organic acids at the sugar moiety. However, any pure resin glycoside had not yet
been isolated and the chemical studies had been limited only to characterization of
the component glycosidic acids and organic acids afforded by alkaline hydrolysis
of a crude resin glycoside (Wagner, H. , 1974).
In 1970, Okabe et al. reinvestigated the components of Pharbitis resin and

isolated two glycosidic acids, pharbitic acids C and D, along with valeric, tiglic,
nilic, isobutyric acid, and (+)-2-methylbutyric acid from its alkaline hydrolysis .
A reexamination of the chemical components of pharbitin was carried out again in
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1990 by Ono, M. et al., who characterized the glycosidic acids as ipurolic acid 110-penta- and 11-0-hexaglycoside.
The effects of the hydroxy acid-containing cathartics on PP2A were
determined using the PP2A 4-MUP inhibition assay. An assay that perhaps uses a
crude PP2A preparation would be much more economical for further studies to be
conducted. Testing these compounds on other enzymes may help to further
explain their cathartic activities. Also, the development of an assay that is not
performed on microscale might be more appropriate for future studies due to the
solubilities of the test samples. Having a maximum volume of 50 µl per well is a
limitation to this assay. This limitation prevents the drugs from being tested at a
scale that is relevant to their actual therapeutic dosage and prevents them from
being assayed at higher concentrations at which more or total inhibition might
take place.
Another limitation of this experiment was the uncertainty of the purity of
the jalapin and convolvulin samples. It may be possible that the slight activation
observed in each data set from the jalapin and convolvulin samples could have
been due to contamination of the enzyme assay by highly hydrophobic
compounds which may have been present in the crude extracts. If this
experiment were to be improved upon, separation of the crude extracts by HPLC
would improve the ability to attain better purity of the isolated samples.

13

C

NMR studies in addition to the 1H NMR studies would enhance the ability to
confirm the molecular structure of the isolated compounds. Performing replicates
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of each microtiter plate would provide more data, which would allow for better
statistical analyses and more certainty in interpreting the results of the experiment.
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CONCLUSIONS
The assay results indicated weak but significant inhibition of PP2A by
these compounds. Okadaic acid almost completely inhibits PP2A in vitro at a 60
nM concentration and can produce diarrhea in humans by consumption of 1 µg of
the toxin. The doses of these crude drugs used to produce catharsis are six orders
larger than the dose of okadaic acid which causes diarrhea in humans. Thus the
weak activities of these compounds may be sufficient to account for the cathartic
action of these drugs. However, in the human body, the bioavailability of these
compounds is unknown. Since the traditional standard dosages of these cathartics
are too large to prepare as samples for a micro-titer assay due to their solubilities,
they were not able to be assayed at higher concentrations at which more or total
inhibition might take place. The possibility that these crude cathartic drugs
inhibit PP2A can not be discounted based on the results ofthis study. It is also
possible that these drugs may cause catharsis by affecting other enzymatic
activities which were not tested. This matter is still open to question.
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Table 1. H NMR Spectral Data for Samples N76-24-5
& N76-24-6 (YSN2246 & YSN2247) (400 MHz, pyridine-d5)
Chemical

Shift

0

Moiety

Carbon#

Umml

#of H's Peak splitting

Rhamnopyranosal

1
2
3
4
5
6

5.51
5.67
5.78
4.18
4.26
1.56

1H
1H
1H
1H
1H
3H

d
dd
dd
dd
dq
d

Glucopyranosal

1
2
3
4
5
6

5.13
4.09
5.78
5.39
4.17
4.42
4.68

1H
1H
1H
1H
1H
1H
1H

d
dd
dd
dd
ddd
dd
dd

Quinovopyranosal

1
2
3
4
5
6

4.82
4.09
5.39
5.04
3.68
1.26

1H
1H
1H
1H
1H
3H

d
dd
dd
dd
dq
d

Rhamnopyranosal'

1
2
3
4
5
6

5.67
5.92
5.99
4.53
4.61
1.45

1H
1H
1H
1H
1H
3H

d
dd
dd
dd
dq
d

Quinovopyranosal'

1
2
3
4
5
6

4.81
4.01
3.55
3.62
3.91
1.65

1H
1H
1H
1H
1H
3H

d
dd
dd
dd
dq
d

Jalapinoyl

2
2.69
11
3.77
16
0.96
3-10, 12-15 1.65

2H
1H
3H
24 H

m
m
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m

Chemical

Shift

0

Moiety

Carbon#

Umml

#of H's Peak splitting

Tiglyl

3
4
5

7.02
1.59
1.82

1H
3H
3H

dq
dd
s

Tiglyl'

3
4
5

7.17
1.36
1.65

1H
3H
3H

dq
dd
s

1.96
2.34
2.69

8H
2H
2H

2.92
1.21
1.07

1H
3H
3H

Acetyl

lsobutyryl

2
3
4
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sept
d
d

Table 2. 1H NMR Spectral Data for Samples N57-174-8
& N57-175-3 (YSN2170 & YSN2171) (400 MHz, pyridine-dS)
Moiety

Carbon#

Chemical Shift d (ppm)# of H's Peak splitting

Glucopyranosal

1
2
3
4
5
6

4.89
4.36
4.58
3.85
3.91
4.28
4.46

1H
1H
1H
1H
1H
1H
1H

d
dd
dd
dd
ddd
dd
dd

Glucopyranosal'

1
2
3
4
5
6

5.85
4.25
4.23
4.21
3.85
4.3
4.47

1H
1H
1H
1H
1H
1H
1H

d
dd
dd
dd
ddd
dd
dd

2
3
4
5
6

5.48
4.54
4.53
4.25
4.38
1.67

1H
1H
1H
1H
1H
3H

d
dd
dd
dd
dq
d

Rhamnopyranosal'

1
2
3
4
5
6

6.32
4.71
4.76
4.5
5.04
1.93

1H
1H
1H
1H
1H
3H

d
dd
dd
dd
dq
d

Quinovopyranosal

1
2
3
4
5
6

5.30
4.21
4.29
3.49
3.85
1.6

1H
1H
1H
1H
1H
3H

d
dd
dd
dd
dq
d

Convolvulinyl

2
2.55
11
3.91
14
0.87
3-10, 12-131 .32

2H
1H
3H
20 H

m
m

Rhamnopyranosal
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m

Moiety

Carbon#

Chemical Shift d (ppm)# of H's Peak splitting

Tiglyl

3
4
5

7.01
1.27
1.93

1H
3H
3H

dq
dd
s

Methylbutyryl

2
3
4
5

2.43
1.6
1.93
0.94
1.27

1H
1H
1H
3H
3H

tq
m
m
t
d

2
3

2.53
1.69

4
5

0.99

1H
1H
1H
3H
3H

tq
m
m
tq
d

2
3
4

2.55
1.27
1.27

1H
3H
3H

sept
d
d

Methylbutyryl'

lsobutyryl
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Table 3. Effective Doses of Cathartic Drugs

Cathartic Drug

Drug Source

Okadaic Acid

Dinoflagellates,
manne sponge

Croton Oil

Seeds

Chemical
Classification
Polyketide

of Croton Phorbol esters

Effective
Dose
1 µg
10-50 mg*

ti_gfia

Seeds of Ricinus Hydroxy-fatty acid 30 ml*
communis
l.{_Ricinoleic Acidl
1.25 g*
Podophyllotoxin Roots
of Lignan

Castor Oil

Jalapin
Convolvulin

Podophyllum
peltatum
Roots of lpomoea Resin glycoside
pur:.g_a
Seeds of Pharbitis Resin glycoside
nil

2 g*
2 g*

*Effective doses listed in the United States Pharmacopeia XX
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50 g tJomoea purga roots
_ _ 200 ml Me OH x 3, suction-filtered through Buchner
funnel lined vw'lll/hatman 9.0 cm 1 filter. evaporated in
rotav apor
MeOH extract, N76-17-3, 6 .15 g
-2 .0 g

N76-17-3
--partitioned beiween 25 ml dd H20 and 25 ml 1-BuOH in
separatory funnel x 3, each layer was evaporated in
rotavapor

H0e~•act.
2

1

76·18·9,

33

mg

I

YSN
2243
100 mg
yellow oil

"T"

•;:::,"::::~:8,165 g

L

Defatted , 1-BuOH-soluble extract, N76-19-2, 1.55 g

Si-gel Column Chromatography: stepwise
elution wl CHCl 3 :Me0H (10 :1, 5 :1, 5 :2,
5 :3, and 5 :4) yielded 76 (4 ml aliquot)

I

f•act;oos

Fr.

Fr.

Fr.

Fr.

Fr.

Fr.

Fr.

1-30, 31-38, 39-46,46, 47-53, 54-63, 64-76,
N76- N76- N76- N76- N76- N76- N7624-1 24-2 24-3 24-4 24-5 24-6 24-7

I I I

YSN
2246

YSN YSN
2246 2247

Figure 7. Outline for the Extraction of Jalapin from Roots of
lpomoea purga
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100 g Phstb/tis nil seeds

~

200 ml MeOH x 3, suction-filtered through Buchner
fl.l'lnel llned w/ Whatman 9.0 an 1 filter paper,
evaporated in rotavapor

MeOH extract, N57-174-2, 4.17 g

I

-2.0 I

g N57-174-2

artltloned between 25 ml dd H:P and 25 ml 1-BuOH In
atory funnel x3, each layer was evaporated In

r
LH-20 Column w/ MeOH
H:z() extract
I
N57-174-8, 730 mg (YSN2171)--1- (YSN2176)

1-BuOH extract
N57-174-7

L

N57-175-2, precipitate

L

25 ml CH:!C'2

_L CH~'2 N57•17s- 1

L

·

Flash column chromatography

C~l3:MeOH:H:z() (6:4:1) yielded 60 (10 ml
aliquot) fractions

I

I MeOH, evaporation

shinywhl1epowcler
LH 20 Col
/ MeOH _j
umnw
•

I

-.-,--.,

l~~,-~1-~,....._-.-1_~,

NS7-175-3,50mg

Fr. 5-8 9-16 17-20 21-2930-35 36-39 40-42 43-60
N57· N57· N57- N57- N57- N57- N57- N57181-1 181-2 181-3 181-4181-5 181-6 181-7 181-8

I

Fr. 5-19, N57-1n-1
(YSN2 170l

I

I

I

LH-20 in MeOH YSN2174 YSN2172 YSN2173

I

YSN2175

I

I

I

LH-20 Column with MeOH

I

YSN2177

I

YSN2178

I

YSN2179

Figure 8. Outline for the Extraction of Convolvulin from Seeds of
Pharbitis nil
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Sam_l?_le #
N76-24-5
N76-24-6
N76-24-7

cm sam_Qle traveled/ cm solvent front
5.7 cm I 7.6 cm
5.4 cm I 7.6 cm
4.6 cm I 7.6 cm
2.3 cm I 7.6 cm
1.4 cm I 7.6 cm
Solvent system: CHCh:MeOH:H 20 (6:4:1)

(

H?lr "
Z'·(,

-

Rf Value
0.75
0.71
0.61
0.30
0.18

.

"'l C.-

~t- l

Figure 9. Thin Layer Chromatography of Ipomoea purga Isolates
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Figure 11. Proposed Structure of Ipomoea purga Isolates, Based on
1

H NMR Analysis
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2.5 cm I 7.7 cm Rf= 0.32

1.1 cm I 7.7 cm Rf= 0.14
0.6 cm I 7.7 cm Rf= 0.08

___

_,

Solvent system: CHCh:MeOH:H2 0 (6:4:1)

Figure 12. Thin Layer Chromatography of Pharbitis nil Isolates
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The Inhibition Effect of Jalapin on PP2A
120 - - - - - - - - -

100

..

~
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1 4
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0 Control: PP2A+4MUP+Tris
• 60 nM Okadaic Acid

80

(J

<
<
N

60
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0..
0..

0~

, D 0.159 mg/ml Jalapin

40
•0.0159 mg/ml
Jalapin

20

00.00159 mg/ml

*

0.05

Jalapin

Incubated at 37 degrees centigrade for 60
min. (PP2A 0.03 units/well, pH 8.5, 4-MUP

[50 uM]
·-----

Figure 16. The Inhibition Effect of Jalapin on PP2A
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The Inhibition Effect of Convolvulin on PP2A
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Figure 17. The Inhibition Effect of Convolvulin on PP2A
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Inhibition Effect of Rlclnolelc Acid on PP2A
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Figure 18. The Inhibition Effect of Ricinoleic Acid on PP2A
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Inhibition Effect of Podophyllotoxin on PP2A
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Figure 19. The Inhibition Effect of Podophyllotoxin on PP2A
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